Zacks Investment ResearchThu, 07 May 2026 20:16:05 GMTLipocine (LPCN) Reports Q1 Loss, Beats Revenue EstimatesLPCN-2.37%
BenzingaThu, 02 Apr 2026 14:58:03 GMTLipocine Stock Plunges After LPCN 1154 Misses Phase 3 Primary EndpointLPCN-2.37%